These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3497420)

  • 21. Effect of cyclosporin A on T cell function in vitro: the mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell.
    Dos Reis GA; Shevach EM
    J Immunol; 1982 Dec; 129(6):2360-7. PubMed ID: 6982917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporin A: recent developments in the mechanism of action and clinical application.
    Feutren G
    Curr Opin Immunol; 1989 Dec; 2(2):239-45. PubMed ID: 2696486
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of Cyclosporin A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas.
    Kaufmann Y; Chang AE; Robb RJ; Rosenberg SA
    J Immunol; 1984 Dec; 133(6):3107-11. PubMed ID: 6436374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of cyclosporin-A on lymphocyte subpopulations.
    Leapman SB; Filo RS; Smith EJ; Smith PG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):405-9. PubMed ID: 6455796
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.
    Larsson EL
    J Immunol; 1980 Jun; 124(6):2828-33. PubMed ID: 6966298
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporin A prevents the appearance of cell surface "activation" antigens.
    Leapman SB; Strong DM; Filo RS; Smith EJ; Brandt GL
    Transplantation; 1982 Aug; 34(2):94-5. PubMed ID: 6215747
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunopharmacology of cyclosporin A].
    Nikitin AV
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):56-66. PubMed ID: 2418777
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.
    Colombani PM; Robb A; Hess AD
    Science; 1985 Apr; 228(4697):337-9. PubMed ID: 3885394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of cyclosporin A on cell-mediated immunity.
    Thomson AW; Webster LM
    Clin Exp Immunol; 1988 Mar; 71(3):369-76. PubMed ID: 2968199
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphocyte activation by low doses of cyclosporin A.
    Diener C; Haroske D; Metzner G; Jäger L
    Acta Biol Med Ger; 1982; 41(6):549-52. PubMed ID: 7148266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
    Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2.
    Wang BS; Heacock EH; Zheng CX; Tilney NL; Mannick JA
    Transplantation; 1982 Apr; 33(4):454-6. PubMed ID: 6978560
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporin A: a selective anti-T cell agent.
    Kahan BD
    Clin Haematol; 1982 Oct; 11(3):743-61. PubMed ID: 6217010
    [No Abstract]   [Full Text] [Related]  

  • 35. T-lymphocyte inhibition by cyclosporine. Potential mechanisms of action.
    Colombani PM; Hess AD
    Biochem Pharmacol; 1987 Nov; 36(22):3789-93. PubMed ID: 3318839
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A.
    Wang BS; Heacock EH; Chang-Xue Z; Tilney NL; Strom TB; Mannick JA
    J Immunol; 1982 Mar; 128(3):1382-5. PubMed ID: 6173434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference of cyclosporin with lymphocyte activation: blockage of the mitogen-induced increases of lysosomal and mitochondrial activities.
    Koponen M; Grieder A; Loor F
    Immunology; 1984 Sep; 53(1):55-62. PubMed ID: 6469286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
    Edwards MC; Nouri AM; Gordon D; Evans FJ
    Mol Pharmacol; 1983 May; 23(3):703-8. PubMed ID: 6865912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cyclosporin A (CyA) and methylprednisolone (MP) on the immune response. II. Further studies of the monocyte - T cell interactions leading to lymphokine production.
    Bendtzen K; Petersen J; Søeberg B
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):159-67. PubMed ID: 6308952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.
    Orosz CG; Fidelus RK; Roopenian DC; Widmer MB; Ferguson RM; Bach FH
    J Immunol; 1982 Nov; 129(5):1865-8. PubMed ID: 6214580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.